Tissue Regenix Group PLC (TRX)

Back to homepage

Company Description

Tissue Regenix Group PLC was incorporated on October 17, 2006 in the United Kingdom. The Company is engaged in the exploitation of technologies in the field of tissue engineering and regenerative medicine. It develops regenerative products to make replacement body parts using biological (human & animal) materials. The Company operates in two geographic sectors, the UK and the USA. Its patent technology dCELL removes DNA and other cellular material from animal and human tissue, leaving an inert, acellular tissue scaffold which can be used to repair damaged organs and skin, while dramatically cutting the risk of rejection by the patient's body...